Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Asperger syndrome future or investigational therapies

Introduction

Overview

Overview

There have been some experimental therapy and suggestions such as oxytocin and treatment with stem cells in patients with Asperger Syndrome (AS).[1]

Future or Investigational Therapies

Future or Investigational Therapies

Experimental therapy for Asperger Syndrome (AS) include:[1]

Oxytocin

  • Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by oxytocin have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS).[2]
  • In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation.[3]  

Stem cells  

  • Treatment of AS and ASD with stem cells is in the early stages.[1]
References

References

  1. ↑ 1.0 1.1 1.2 Tarazi FI, Sahli ZT, Pleskow J, Mousa SA (2015). “Asperger’s syndrome: diagnosis, comorbidity and therapy”. Expert Rev Neurother. 15 (3): 281–93. doi:10.1586/14737175.2015.1009898. PMID 25655905.
  2. ↑ Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR; et al. (2003). “Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders”. Neuropsychopharmacology. 28 (1): 193–8. doi:10.1038/sj.npp.1300021. PMID 12496956.
  3. ↑ Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010). “Promoting social behavior with oxytocin in high-functioning autism spectrum disorders”. Proc Natl Acad Sci U S A. 107 (9): 4389–94. doi:10.1073/pnas.0910249107. PMC 2840168. PMID 20160081.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]